Specifically, the inhibition rates for IL-1β were 10.79 ± 0.45% and 23.25 ± 0.29% in serum, 4.50 ± 1.52% and 19.92 ± 1.03% in liver tissue, 7.20 ± 0.18% and 18.26 ± 1.09% in spleen tissue, and 0.64 ± 0.60% and 18.43 ± 1.02% in tumor tissue. The gene discussed is IL1B; the disease is neoplasm.